Who is sponsoring NCT04294355?

NCT04294355 is sponsored by The University of Hong Kong.

What condition does NCT04294355 study?

NCT04294355 studies Colon Adenoma, Colon Polyp.

Is NCT04294355 still recruiting?

NCT04294355 is currently completed. Last updated 21 April 2022.

Last reviewed 2022-04-21 · How we verify

NCT04294355

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Artificial Intelligence-assisted Colonoscopy on Detection of Missed Proximal Lesions

Completed NA Last updated 21 April 2022

What this trial tests

NA trial testing Artificial intelligence-Assisted colonoscopy in Colon Adenoma in 216 participants. Completed in 15 April 2022.

Timeline

1 March 2021

Primary endpoint
31 March 2022

15 April 2022

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	216
Start date	1 March 2021
Primary completion	31 March 2022
Estimated completion	15 April 2022
Sites	3 locations across China, Singapore, Vietnam

Drugs / interventions tested

Artificial intelligence-Assisted colonoscopy
Conventional colonoscopy

Conditions studied

Colon Adenoma — all drugs for Colon Adenoma →
Colon Polyp — all drugs for Colon Polyp →

Sponsor

The University of Hong Kong

Who can join

40 and older, any sex, with Colon Adenoma or Colon Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective multi-center randomized study is to determine whether the use of artificial intelligence (AI)-assistance could reduce the miss rates of polyps and adenomas in the proximal colon during tandem examination

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Computer-assisted detection versus conventional colonoscopy for proximal colonic lesions: a multicenter, randomized, tandem-colonoscopy study.
Lui TKL, Hang DV, Tsao SKK, Hui CKY, et al · · 2023 · cited 14× · PMID 36208795 · DOI 10.1016/j.gie.2022.09.020

Verify or expand the search:

Other recruiting trials for Colon Adenoma

Currently open trials in the same condition.

NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
NCT05041478 — Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC) · NA · recruiting
NCT05355363 — Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay · NA · recruiting
NCT05402696 — St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C) · recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04294355 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 21 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04294355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing